Raymond James Financial Portfolio holdings
Raymond James Financial, founded in 1962 by Robert James and headquartered in St. Petersburg, Florida, is a diversified financial services firm managing over $1.5 trillion in client assets as of late 2024, primarily focused on wealth management, investment banking, and brokerage services. Known for its advisor-centric model, the firm supports over 8,900 financial advisors across the U.S., Canada, and the UK, offering personalized financial planning, retirement solutions, and investment products to individuals, small businesses, and institutions. Its investment banking arm specializes in middle-market mergers, acquisitions, and equity offerings, while its Raymond James Bank provides lending and deposit services. With a reputation for a conservative, client-first culture and steady growth—including a notable acquisition of TriState Capital in 2022—Raymond James stands out as a resilient, relationship-driven player in the financial industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$809M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$396M |
| 3 |
Zoetis
ZTS
|
+$278M |
| 4 |
iShares Core MSCI Europe ETF
IEUR
|
+$268M |
| 5 |
Microsoft
MSFT
|
+$202M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$433M |
| 2 |
Medtronic
MDT
|
+$371M |
| 3 |
Bank of America
BAC
|
+$124M |
| 4 |
Corning
GLW
|
+$123M |
| 5 |
Vanguard FTSE Pacific ETF
VPL
|
+$114M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.68% |
| 2 | Financials | 8.02% |
| 3 | Industrials | 7.08% |
| 4 | Healthcare | 6.16% |
| 5 | Consumer Discretionary | 5.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3826
Babcock & Wilcox
BW
$1.32B
| $1.03M | ﹤0.01% |
70,287
+59,280
| +539% | +$623K |
|
3827
Rigel Pharmaceuticals
RIGL
$778M
| $1.03M | ﹤0.01% |
38,133
-5,622
| -13% | -$189K |
|
3828
International General Insurance
IGIC
$1.13B
| $1.03M | ﹤0.01% |
42,338
-5,101
| -11% | -$125K |
|
3829
Intapp
INTA
$2.99B
| $1.02M | ﹤0.01% |
39,823
+3,166
| +9% | +$94.4K |
|
3830
Tenable Holdings
TENB
$4.04B
| $1.02M | ﹤0.01% |
60,032
+11,057
| +23% | +$232K |
|
3831
Electromed
ELMD
$353M
| $1.01M | ﹤0.01% |
43,269
-499
| -1% | -$13K |
|
3832
AbCellera Biologics
ABCL
$2.85B
| $1.01M | ﹤0.01% |
289,836
+42,786
| +17% | +$154K |
|
3833
AB US Large Cap Strategic Equities ETF
LRGC
$1.35B
| $1.01M | ﹤0.01% |
13,746
-57,844
| -81% | -$4.45M |
|
|
FINS
3834
Angel Oak Financial Strategies Income Term Trust
FINS
$422M
| $1.01M | ﹤0.01% |
78,999
-1,083
| -1% | -$14.1K |
|
3835
QuickLogic
QUIK
$244M
| $1.01M | ﹤0.01% |
107,255
-8,992
| -8% | -$73.4K |
|
|
FBLA
3836
FB Bancorp
FBLA
$250M
| $1.01M | ﹤0.01% |
73,179
+63,179
| +632% | +$834K |
|
3837
BondBloxx Bloomberg One Year Target Duration US Treasury ETF
XONE
$843M
| $1M | ﹤0.01% |
20,287
+2,304
| +13% | +$114K |
|
3838
AXS Green Alpha ETF
NXTE
$51M
| $1M | ﹤0.01% |
25,531
+8,661
| +51% | +$356K |
|
3839
Aclaris Therapeutics
ACRS
$868M
| $999K | ﹤0.01% |
266,448
-3,236
| -1% | -$10.9K |
|
3840
Strive 1000 Growth ETF
STXG
$154M
| $999K | ﹤0.01% |
+21,290
| New | +$1.06M |
|
3841
iShares MSCI Australia ETF
EWA
$1.47B
| $998K | ﹤0.01% |
35,944
-304,785
| -89% | -$8.56M |
|
3842
Spyre Therapeutics
SYRE
$9.29B
| $996K | ﹤0.01% |
+19,755
| New | +$745K |
|
3843
Icahn Enterprises
IEP
$5.28B
| $995K | ﹤0.01% |
131,828
+22,474
| +21% | +$176K |
|
3844
Hingham Institution for Saving
HIFS
$657M
| $995K | ﹤0.01% |
3,481
+2,294
| +193% | +$670K |
|
|
IGR
3845
CBRE Global Real Estate Income Fund
IGR
$707M
| $995K | ﹤0.01% |
226,645
+37,567
| +20% | +$177K |
|
3846
PENN Entertainment
PENN
$2.53B
| $994K | ﹤0.01% |
66,122
-853
| -1% | -$11.9K |
|
3847
Box
BOX
$4.65B
| $992K | ﹤0.01% |
41,973
+2,604
| +7% | +$65.5K |
|
|
PAXS
3848
PIMCO Access Income Fund
PAXS
$674M
| $992K | ﹤0.01% |
68,837
+22,075
| +47% | +$338K |
|
3849
Franklin FTSE Canada ETF
FLCA
$857M
| $992K | ﹤0.01% |
20,263
-2,174
| -10% | -$108K |
|
3850
Klaviyo
KVYO
$5.09B
| $991K | ﹤0.01% |
50,945
-11,315
| -18% | -$243K |
|
Similar funds
Raymond James Financial's Q1 2026 Portfolio in Review
As of Q1 2026, Raymond James Financial held 5,490 positions worth $324B, up 0.94% from $321B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Raymond James Financial's Q1 2026 filing shows 349 new, 2,830 increased, 1,948 reduced and 210 closed positions. Its largest new stake was Lazard International Dynamic Equity ETF: 663,484 shares worth $21.1M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $433M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Financials and Industrials.
- Raymond James Financial's largest Q1 2026 buy was Lazard International Dynamic Equity ETF: 663,484 shares worth $21.1M.
- Raymond James Financial added most to Vanguard S&P 500 ETF in Q1 2026, an estimated $809M increase.
- Raymond James Financial's biggest Q1 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $433M.
- Raymond James Financial fully exited New Gold Inc in Q1 2026, selling an estimated $19M.
- Raymond James Financial's ten largest holdings make up 21% of its $324B portfolio in Q1 2026.
- Raymond James Financial opened 349 new positions and closed 210 in Q1 2026.
- Raymond James Financial's portfolio value rose 0.94% quarter-over-quarter to $324B.
Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.